HIF1A and metabolic dysfunction-associated steatotic liver disease: Adipose tissue hypoxia is well documented in individuals with obesity (50), and HIF1α activation occurs in hepatocytes of patients with nonalcoholic fatty liver disease, which is present in approximately 75% of individuals with obesity (51, 52).